Kevin P Starr insider trades: Jounce Therapeutics (JNCE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
and 17 more companies
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | JNCE | ↓ Sell | 1,900,000 | $8.38 | $15.9M | Direct | Nov 16, 2021 (4d) |
| Jun 16, 2021 | SAGE | ↑ Buy | 17,842 | $56.05 | $1000K | Direct | Jun 17, 2021 (1d) |
| Jun 4, 2021 | RVMD | ↓ Sell | 543,113 | $30.21 | $16.4M | Direct | Jun 7, 2021 (3d) |
| May 26, 2021 | RVMD | ↓ Sell | 1,366,204 | $30.57 | $41.8M | Direct | May 27, 2021 (1d) |
| May 25, 2021 | JNCE | ↓ Sell | 552,520 | $8.00 | $4.4M | Direct | May 27, 2021 (2d) |
| Mar 1, 2021 | JNCE | ↓ Sell | 1,450,000 | $11.75 | $17.0M | Direct | Mar 3, 2021 (2d) |
| Jan 14, 2021 | RLAY | ↓ Sell | 2,811,197 | $40.74 | $114.5M | Indirect | Jan 14, 2021 (0d) |
| Jan 13, 2021 | RLAY | ↓ Sell | 2,811,197 | $40.06 | $112.6M | Direct | Jan 14, 2021 (1d) |
| Nov 19, 2020 | JNCE | ↓ Sell | 15,000 | $7.00 | $105K | Direct | Nov 23, 2020 (4d) |
| Nov 17, 2020 | JNCE | ↓ Sell | 15,000 | $7.25 | $109K | Direct | Nov 19, 2020 (2d) |
| Jul 22, 2019 | FULC | ↑ Buy | 81,250 | $16.00 | $1.3M | Direct | Jul 22, 2019 (0d) |
| Jul 23, 2018 | CNST | ↑ Buy | 266,667 | $15.00 | $4.0M | Direct | Jul 24, 2018 (1d) |
| Apr 18, 2018 | SAGE | ↓ Sell | 59,000 | $168.85 | $10.0M | Direct | Apr 19, 2018 (1d) |
| Jan 3, 2018 | MYOK | ↓ Sell | 816,326 | $42.00 | $34.3M | Indirect | Jan 5, 2018 (2d) |
| Nov 6, 2017 | ALNA | ↑ Buy | 215,000 | $14.00 | $3.0M | Direct | Nov 6, 2017 (0d) |
| Oct 3, 2017 | MYOK | ↓ Sell | 75,313 | $40.28 | $3.0M | Direct | Oct 4, 2017 (1d) |
| Sep 26, 2017 | MYOK | ↓ Sell | 601,400 | $43.00 | $25.9M | Indirect | Sep 27, 2017 (1d) |
| Sep 8, 2017 | MYOK | ↓ Sell | 201,250 | $41.01 | $8.3M | Indirect | Sep 12, 2017 (4d) |
| Apr 12, 2017 | CTMX | ↓ Sell | 28,357 | $16.36 | $464K | Direct | Apr 14, 2017 (2d) |
| Mar 27, 2017 | CTMX | ↓ Sell | 1,650,000 | $17.39 | $28.7M | Direct | Mar 27, 2017 (0d) |
| Mar 2, 2017 | GBT | ↓ Sell | 2,045,294 | $25.54 | $52.2M | Direct | Mar 6, 2017 (4d) |
| Feb 7, 2017 | BPMC | ↓ Sell | 1,000,000 | $35.27 | $35.3M | Direct | Feb 9, 2017 (2d) |
| Dec 19, 2016 | BPMC | ↓ Sell | 106,489 | $28.19 | $3.0M | Direct | Dec 21, 2016 (2d) |
| Dec 16, 2016 | GBT | ↓ Sell | 108,955 | $16.00 | $1.7M | Direct | Dec 20, 2016 (4d) |
| Nov 14, 2016 | GBT | ↓ Sell | 2,000,000 | $19.36 | $38.7M | Direct | Nov 16, 2016 (2d) |
| Sep 6, 2016 | EDIT | ↓ Sell | 5,890 | $15.90 | $94K | Direct | Sep 7, 2016 (1d) |
| May 16, 2016 | SAGE | ↓ Sell | 850,000 | $31.25 | $26.6M | Indirect | May 18, 2016 (2d) |
| Nov 12, 2015 | ALNY | ↓ Sell | 75,000 | $103.89 | $7.8M | Direct | Nov 13, 2015 (1d) |
| Sep 24, 2015 | ZFGN | ↓ Sell | 136,579 | $43.90 | $6.0M | Indirect | Sep 25, 2015 (1d) |
| Sep 25, 2014 | ALNY | ↓ Sell | 90,000 | $78.09 | $7.0M | Direct | Sep 26, 2014 (1d) |
| Mar 26, 2013 | ALNY | ↓ Sell | 52,631 | $23.49 | $1.2M | Direct | Mar 26, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kevin P Starr's insider trades
Kevin P Starr is a 10% owner of Jounce Therapeutics (JNCE). Since Mar 26, 2013, Kevin has reported 4 open-market purchases worth $9.3M and 27 sales worth $613.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (52 filings), grants and awards (32 filings), conversions (20 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.